{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:33:46Z","timestamp":1761514426924,"version":"3.40.5"},"reference-count":42,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,11]]},"DOI":"10.20945\/2359-3997000000145","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T13:17:43Z","timestamp":1563974263000},"source":"Crossref","is-referenced-by-count":4,"title":["Pheochromocytoma and paraganglioma: implications of germline mutation investigation for treatment, screening, and surveillance"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4739-5260","authenticated-orcid":false,"given":"Ana Milena","family":"G\u00f3mez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1279-9302","authenticated-orcid":false,"given":"Diogo Cordeiro","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1631-0105","authenticated-orcid":false,"given":"Alexandre Andr\u00e9 Balieiro","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3185-9187","authenticated-orcid":false,"given":"Daniele Paix\u00e3o","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6894-1219","authenticated-orcid":false,"given":"Maria Isabel","family":"Achatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1187-1384","authenticated-orcid":false,"given":"Maria Nirvana","family":"Formiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8510","reference":[{"issue":"9","key":"key20190724090230_B1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/jmg.39.9.617","article-title":"Hereditary paraganglioma targets diverse paraganglia","volume":"39","author":"Baysal","year":"2002","unstructured":"1. Baysal BE. Hereditary paraganglioma targets diverse paraganglia. J Med Genet. 2002;39(9):617-22.","journal-title":"J Med Genet"},{"key":"key20190724090230_B2","volume-title":"Hereditary Paraganglioma-Pheochromocytoma Syndromes","author":"Kirmani","year":"2014","unstructured":"2. Kirmani S, Young WF. Hereditary Paraganglioma-Pheochromocytoma Syndromes. In: Pagon RA, Adam MP, Ardinger HH, et al. (eds): Seattle (WA): GeneReviews(R); 2014."},{"issue":"5","key":"key20190724090230_B3","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1210\/jc.2008-2419","article-title":"Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and\/or functional or nonfunctional paragangliomas","volume":"94","author":"Mannelli","year":"2009","unstructured":"3. Mannelli M, Castellano M, Schiavi F, Filetti S, Giacch\u00e8 M, Mori L, et al. Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and\/or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab. 2009;94(5):1541-7.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key20190724090230_B4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1055\/s-0032-1304594","article-title":"A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma","volume":"44","author":"Buffet","year":"2012","unstructured":"4. Buffet A, Venisse A, Nau V, Roncellin I, Boccio V, Le Pottier N, et al. A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma. Horm Metab Res. 2012;44(5):359-66.","journal-title":"Horm Metab Res"},{"issue":"5","key":"key20190724090230_B5","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1245\/s10434-013-2942-5","article-title":"Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing","volume":"20","author":"Fishbein","year":"2013","unstructured":"5. Fishbein L, Merrill S, Fraker DL, Cohen DL, Nathanson KL. Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing. Ann Surg Oncol. 2013;20(5):1444-50.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"key20190724090230_B6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/EJE-16-0126","article-title":"Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma","volume":"175","author":"Pandit","year":"2016","unstructured":"6. Pandit R, Khadilkar K, Sarathi V, Kasaliwal R, Goroshi M, Khare S. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma. Eur J Endocrinol. 2016;175(4):311-23.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"key20190724090230_B7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/cen.12530","article-title":"Testing for germline mutations in sporadic pheochromocytoma\/paraganglioma: a systematic review","volume":"82","author":"Brito","year":"2015","unstructured":"7. Brito JP, Asi N, Bancos I, Gionfriddo MR, Zeballos-Palacios CL, Leppin AL, et al. Testing for germline mutations in sporadic pheochromocytoma\/paraganglioma: a systematic review. Clin Endocrinol (Oxf). 2015;82(3):338-45.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"key20190724090230_B8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/jmedgenet-2015-103218","article-title":"Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients","volume":"52","author":"Curras-Freixes","year":"2015","unstructured":"8. Curras-Freixes M, Inglada-Perez L, Mancikova V, Montero-Conde C, Let\u00f3n R, Comino-M\u00e9ndez I, et al. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients. J Med Genet. 2015;52(10):647-56.","journal-title":"J Med Genet"},{"issue":"5","key":"key20190724090230_B9","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1210\/jc.2008-2756","article-title":"Genetics of pheochromocytoma and paraganglioma in Spanish patients","volume":"94","author":"Cascon","year":"2009","unstructured":"9. Cascon A, Pita G, Burnichon N, Landa I, L\u00f3pez-Jim\u00e9nez E, Montero-Conde C, et al. Genetics of pheochromocytoma and paraganglioma in Spanish patients. J Clin Endocrinol Metab. 2009;94(5):1701-5.","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"key20190724090230_B10","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJMoa020152","article-title":"Germ-line mutations in nonsyndromic pheochromocytoma","volume":"346","author":"Neumann","year":"2002","unstructured":"10. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346(19):1459-66.","journal-title":"N Engl J Med"},{"issue":"3","key":"key20190724090230_B11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MED.0000000000000059","article-title":"Genetic testing in the clinical care of patients with pheochromocytoma and paraganglioma","volume":"21","author":"Rana","year":"2014","unstructured":"11. Rana HQ, Rainville IR, Vaidya A. Genetic testing in the clinical care of patients with pheochromocytoma and paraganglioma. Curr Opin Endocrinol Diabetes Obes 2014;21(3):166-76.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"8","key":"key20190724090230_B12","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.292.8.943","article-title":"Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations","volume":"292","author":"Neumann","year":"2004","unstructured":"12. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA. 2004;292(8):943-51.","journal-title":"JAMA"},{"issue":"12","key":"key20190724090230_B13","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/jmedgenet-2012-101192","article-title":"Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysis","volume":"49","author":"van Hulsteijn","year":"2012","unstructured":"13. van Hulsteijn LT, Dekkers OM, Hes FJ, Smit JW, Corssmit EP. Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysis. J Med Genet. 2012;49(12):768-76.","journal-title":"J Med Genet"},{"issue":"5","key":"key20190724090230_B14","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1210\/jc.2007-1989","article-title":"Paraganglioma after maternal transmission of a succinate dehydrogenase gene mutation","volume":"93","author":"Pigny","year":"2008","unstructured":"14. Pigny P, Vincent A, Cardot Bauters C, Bertrand M, de Montpreville VT, Crepin M, et al. Paraganglioma after maternal transmission of a succinate dehydrogenase gene mutation. J Clin Endocrinol Metab. 2008;93(5):1609-15.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"key20190724090230_B15","doi-asserted-by":"crossref","first-page":"E2009","DOI":"10.1210\/jc.2011-1244","article-title":"Molecular analysis of pheochromocytoma after maternal transmission of SDHD mutation elucidates mechanism of parent-of-origin effect","volume":"96","author":"Yeap","year":"2011","unstructured":"15. Yeap PM, Tobias ES, Mavraki E, Fletcher A, Bradshaw N, Freel EM, et al. Molecular analysis of pheochromocytoma after maternal transmission of SDHD mutation elucidates mechanism of parent-of-origin effect. J Clin Endocrinol Metab. 2011;96(12):E2009-13.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20190724090230_B16","doi-asserted-by":"crossref","DOI":"10.1186\/s12881-014-0111-8","article-title":"Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutations","volume":"15","author":"Bayley","year":"2014","unstructured":"16. Bayley JP, Oldenburg RA, Nuk J, Hoekstra AS, van der Meer CA, Korpershoek E, et al. Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutations. BMC Med Genet. 2014;15:111.","journal-title":"BMC Med Genet"},{"issue":"1","key":"key20190724090230_B17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2796.2009.02110.x","article-title":"The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications","volume":"266","author":"Stratakis","year":"2009","unstructured":"17. Stratakis CA, Carney JA. The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications. J Intern Med. 2009;266(1):43-52.","journal-title":"J Intern Med"},{"issue":"17","key":"key20190724090230_B18","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/djn254","article-title":"Germline SDHB mutations and familial renal cell carcinoma","volume":"100","author":"Ricketts","year":"2008","unstructured":"18. Ricketts C, Woodward ER, Killick P, Morris MR, Astuti D, Latif F, et al. Germline SDHB mutations and familial renal cell carcinoma. J Natl Cancer Inst. 2008;100(17):1260-2.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"key20190724090230_B19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ejhg.2015.142","article-title":"Carney triad can be (rarely) associated with germline succinate dehydrogenase defects","volume":"24","author":"Boikos","year":"2016","unstructured":"19. Boikos SA, Xekouki P, Fumagalli E, Faucz FR, Raygada M, Szarek E, et al. Carney triad can be (rarely) associated with germline succinate dehydrogenase defects. Eur J Hum Genet. 2016;24(4):569-73.","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"key20190724090230_B20","doi-asserted-by":"crossref","first-page":"E357","DOI":"10.1210\/jc.2011-1179","article-title":"Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: A new association for SDH?","volume":"97","author":"Xekouki","year":"2012","unstructured":"20. Xekouki P, Pacak K, Almeida M, Wassif CA, Rustin P, Nesterova M, et al. Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: A new association for SDH? J Clin Endocrinol Metab. 2012;97(3):E357-66.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"key20190724090230_B21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.861","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","author":"Comino-Mendez","year":"2011","unstructured":"21. Comino-Mendez I, Gracia-Aznarez FJ, Schiavi F, Landa I, Leandro-Garc\u00eda LJ, Let\u00f3n R, et al. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet. 2011;43(7):663-7.","journal-title":"Nat Genet"},{"issue":"3","key":"key20190724090230_B22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ng.533","article-title":"Germline mutations in TMEM127 confer susceptibility to pheochromocytoma","volume":"42","author":"Qin","year":"2010","unstructured":"22. Qin Y, Yao L, King EE, Buddavarapu K, Lenci RE, Chocron ES, et al. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet. 2010;42(3):229-33.","journal-title":"Nat Genet"},{"issue":"6","key":"key20190724090230_B23","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","unstructured":"23. Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915-42.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key20190724090230_B24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","unstructured":"24. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-24.","journal-title":"Genet Med"},{"issue":"4","key":"key20190724090230_B25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.185","article-title":"Consensus statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas","volume":"13","author":"Toledo","year":"2017","unstructured":"25. Toledo RA, Burnichon N, Cascon A, Benn DE, Bayley JP, Welander J, et al. Consensus statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas. Nat Rev Endocrinol. 2017;13(4):233-47.","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"key20190724090230_B26","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2008-2504","article-title":"The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas","volume":"94","author":"Burnichon","year":"2009","unstructured":"26. Burnichon N, Rohmer V, Amar L, Herman P, Leboulleux S, Darrouzet V, et al. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metab. 2009;94(8):2817-27.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key20190724090230_B27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/gcc.1142","article-title":"Novel mutations in the SDHD gene in pedigrees with familial carotid body paraganglioma and sensorineural hearing loss","volume":"31","author":"Badenhop","year":"2001","unstructured":"27. Badenhop RF, Cherian S, Lord RS, Baysal BE, Taschner PE, Schofield PR. Novel mutations in the SDHD gene in pedigrees with familial carotid body paraganglioma and sensorineural hearing loss. Genes Chromosomes Cancer. 2001;31(3):255-63.","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"key20190724090230_B28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc3648","article-title":"Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity","volume":"14","author":"Dahia","year":"2014","unstructured":"28. Dahia PL. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer. 2014;14(2):108-19.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"key20190724090230_B29","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1210\/jc.2007-0709","article-title":"Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas","volume":"92","author":"Amar","year":"2007","unstructured":"29. Amar L, Baudin E, Burnichon N, Peyrard S, Silvera S, Bertherat J, et al. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab. 2007;92(10):3822-8.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"key20190724090230_B30","doi-asserted-by":"crossref","first-page":"T201","DOI":"10.1530\/ERC-18-0085","article-title":"65 years of the double helix: Genetics informs precision practice in the diagnosis and management of pheochromocytoma","volume":"25","author":"Neumann","year":"2018","unstructured":"30. Neumann HP, Young WF Jr, Krauss T, Bayley JP, Schiavi F, Opocher G, et al. 65 years of the double helix: Genetics informs precision practice in the diagnosis and management of pheochromocytoma. Endocr Relat Cancer. 2018;25(8):T201-T219.","journal-title":"Endocr Relat Cancer"},{"key":"key20190724090230_B31","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jso.23157","article-title":"Hereditary pheochromocytoma and paraganglioma","volume":"106","author":"Mazzaglia","year":"2012","unstructured":"31. Mazzaglia PJ. Hereditary pheochromocytoma and paraganglioma. J Surg Oncol. 2012;106:580-5.","journal-title":"J Surg Oncol"},{"issue":"3","key":"key20190724090230_B32","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/jc.2006-2315","article-title":"Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas","volume":"92","author":"Timmers","year":"2007","unstructured":"32. Timmers HJ, Kozupa A, Eisenhofer G, Raygada M, Adams KT, Solis D, et al. Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. J Clin Endocrinol Metab. 2007;92(3):779-86.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key20190724090230_B33","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2005-1862","article-title":"Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes","volume":"91","author":"Benn","year":"2006","unstructured":"33. Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, et al. Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes. J Clin Endocrinol Metab. 2006;91(3):827-36.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key20190724090230_B34","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s00439-003-0969-6","article-title":"Altitude is a phenotypic modifier in hereditary paraganglioma type 1: Evidence for an oxygen-sensing defect","volume":"113","author":"Astrom","year":"2003","unstructured":"34. Astrom K, Cohen JE, Willett-Brozick JE, Aston CE, Baysal BE. Altitude is a phenotypic modifier in hereditary paraganglioma type 1: Evidence for an oxygen-sensing defect. Hum Genet. 2003;113(3):228-37.","journal-title":"Hum Genet"},{"issue":"3","key":"key20190724090230_B35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc1013","article-title":"A role for mitochondrial enzymes in inherited neoplasia and beyond","volume":"3","author":"Eng","year":"2003","unstructured":"35. Eng C, Kiuru M, Fernandez MJ, Aaltonen LA. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer. 2003;3(3):193-202.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"key20190724090230_B36","doi-asserted-by":"crossref","first-page":"E1472","DOI":"10.1210\/jc.2011-1043","article-title":"SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas","volume":"96","author":"Korpershoek","year":"2011","unstructured":"36. Korpershoek E, Favier J, Gaal J, Burnichon N, van Gessel B, Oudijk L, et al. SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. J Clin Endocrinol Metab. 2011;96(9):E1472-6.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"key20190724090230_B37","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S1470-2045(09)70164-0","article-title":"An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis","volume":"10","author":"Van Nederveen","year":"2009","unstructured":"37. Van Nederveen FH, Gaal J, Favier J, Korpershoek E, Oldenburg RA, de Bruyn EM, et al. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol. 2009;10(8):764-71.","journal-title":"Lancet Oncol"},{"issue":"11","key":"key20190724090230_B38","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/apm.12269","article-title":"Usefulness of succinate dehydrogenase B (SDHB) immunohistochemistry in guiding mutational screening among patients with pheochromocytoma-paraganglioma syndromes","volume":"122","author":"Pai","year":"2014","unstructured":"38. Pai R, Manipadam MT, Singh P, Ebenazer A, Samuel P, Rajaratnam S. Usefulness of succinate dehydrogenase B (SDHB) immunohistochemistry in guiding mutational screening among patients with pheochromocytoma-paraganglioma syndromes. APMIS. 2014;122(11):1130-5.","journal-title":"APMIS"},{"issue":"1","key":"key20190724090230_B39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.hoc.2015.09.006","article-title":"Pheochromocytoma and Paraganglioma: Genetics, Diagnosis, and Treatment","volume":"30","author":"Fishbein","year":"2016","unstructured":"39. Fishbein L. Pheochromocytoma and Paraganglioma: Genetics, Diagnosis, and Treatment. Hematol Oncol Clin North Am. 2016;30(1):135-50.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"key20190724090230_B40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/jmedgenet-2016-104297","article-title":"Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma","volume":"54","author":"Burnichon","year":"2017","unstructured":"40. Burnichon N, Mazzella JM, Drui D, Amar L, Bertherat J, Coupier I, et al. Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma. J Med Genet. 2017;54(2):125-33.","journal-title":"J Med Genet"},{"key":"key20190724090230_B41","author":"NCCN","year":"2018","unstructured":"41. NCCN. Neuroendocrine Tumors, Version 4. 2018. In: National Comprehensive Cancer Network Guidelines; 2018.","journal-title":"Neuroendocrine Tumors, Version 4. 2018"},{"issue":"13","key":"key20190724090230_B42","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1056\/NEJMc1716652","article-title":"EPAS1 Mutations and Paragangliomas in Cyanotic Congenital Heart Disease","volume":"378","author":"Vaidya","year":"2018","unstructured":"42. Vaidya A, Flores SK, Cheng ZM, Nicolas M, Deng Y, Opotowsky AR, et al. EPAS1 Mutations and Paragangliomas in Cyanotic Congenital Heart Disease. N Engl J Med. 2018 Mar 29;378(13):1259-61.","journal-title":"N Engl J Med"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T09:03:11Z","timestamp":1721552591000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972019005006101&lng=en&nrm=iso&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,11]]},"references-count":42,"alternative-id":["10.20945\/2359-3997000000145"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000145","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"type":"print","value":"2359-3997"},{"type":"electronic","value":"2359-4292"}],"subject":[],"published":{"date-parts":[[2019,7,11]]}}}